Stocktoria
Lantern Pharma Inc. LTRN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-06-11
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$18.0M | -$22.2M | -$17.9M | -$14.4M | -$12.6M |
| Net income | -$17.1M | -$20.8M | -$16.0M | -$14.3M | -$12.4M |
| Operating cash flow | -$15.7M | -$17.8M | -$14.3M | -$12.8M | -$10.6M |
| Free cash flow | -$15.7M | -$17.8M | -$14.4M | -$12.8M | -$10.6M |
| Total assets | $11.0M | $25.6M | $43.6M | $58.8M | $74.0M |
| Total liabilities | $4.5M | $4.4M | $2.7M | $2.8M | $2.4M |
| Shareholders' equity | $6.5M | $21.2M | $40.9M | $56.0M | $71.6M |
| Ratios | |||||
| Return on assets | -155.1% | -81.3% | -36.6% | -24.2% | -16.7% |
| Return on equity | -262.0% | -98.1% | -39.0% | -25.4% | -17.3% |
| Current ratio | 2.40 | 5.83 | 16.18 | 20.99 | 31.26 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 116,000 | $158,920 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001763950 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.